Conference Proceedings
CLINICAL EVALUATION OF THE RESISTANCEPLUS™ MG KIT, FOR DETECTION OF MYCOPLASMA GENITALIUM AND SCREENING FOR MACROLIDE RESISTANCE
Simon Erskine, Litty Tan, Jenny Su, Gerald Murray, Catriona Bradshaw, Christopher Fairley, Suzanne Garland, Elisa Mokany, Sepehr Tabrizi
SEXUALLY TRANSMITTED INFECTIONS | BMJ PUBLISHING GROUP | Published : 2017
Abstract
IntroductionEuropean guidelines onMycoplasma genitalium(MG) infections and on the mangement of non-gonococcal urethritis strongly recommend NAAT testing for MG and screening for macrolide resistance. The ResistancePlus™ MG kit has been developed for the simultaneous detection of MG and five mutations in the 23S rRNA gene associated with azithromycin resistance.MethodsThe ResistancePlus™ MG kit (SpeeDx) was evaluated in a prospective-restrospective study on 182 urogenital samples from patients routinely tested for Chlamydia and gonorrhoea. The ResistancePlus™ MG (550) kit was performed using the 7500 Fast (Applied Biosystems), after sample extraction on the MagNA Pure 96 Instrument (Roche) us..
View full abstract